Trial · NCT03566303
Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis
NCT03566303, Phase 2, Phase 3, Terminated, Hospital Geral Roberto Santos
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis. Trials, record NCT03566303. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03566303
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis
- NCT number
- NCT03566303
- Status
- Terminated
- Phases
- Phase 2, Phase 3
- Enrollment
- 50 participants, actual
- Lead sponsor
- Hospital Geral Roberto Santos
- Conditions
- Prostheses and Implants, Stroke, Valve Heart Disease, Anticoagulants and Bleeding Disorders
- Interventions
- Rivaroxaban 15 mg, Warfarin
- First posted
- 2018-06-25
- Last updated
- 2020-05-15
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patients with thromboembolic events: Stroke, transient ischemic attack (TIA), silent brain infarction (SBI) and systemic embolism (SE). | 90 days | The primary endpoint was defined as stroke, TIA, SBI and systemic embolism |
| Primary | major or clinically relevant nonmajor bleeding | 90 days | The primary safety outcome was major or clinically relevant nonmajor bleeding according to the International Society on Thrombosis and Haemostasis (ISTH) criteria and Bleeding Academic Research Consortium (BARC) |
| Secondary | Patients with e of stroke/TIA/SBI/SE and/or death from any cause. | 90 days | Combined outcome |
| Secondary | Cases of myocardial infarction during of follow-up | 90 days | Myocardial infarction in the course of treatment |
| Secondary | New cases of valve thrombosis with or without symptoms | 90 days | Clinical or asymptomatic valve thrombosis |
| Secondary | New intracardiac thrombus detected at the end of clinical follow-up by transesophageal echocardiogram | 90 days | Emergence of intracardiac thrombus seen on transesophageal echocardiogram |
| Other | Cases of minor bleeding | 90 days | Any minor bleeding |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03566303
GET https://conductscience.org/api/trials/v1/NCT03566303/registered